Sherry Aulin - Net Worth and Insider Trading

Sherry Aulin Net Worth

The estimated net worth of Sherry Aulin is at least $0 dollars as of 2024-11-13. Sherry Aulin is the CFO of Xenon Pharmaceuticals Inc and owns about 0 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $0. Details can be seen in Sherry Aulin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sherry Aulin has not made any transactions after 2022-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sherry Aulin

To

Sherry Aulin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sherry Aulin owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .

Click here to see the complete history of Sherry Aulin’s form 4 insider trades.

Insider Ownership Summary of Sherry Aulin

Ticker Comapny Transaction Date Type of Owner
XENE Xenon Pharmaceuticals Inc 2022-09-02 Chief Financial Officer

Sherry Aulin Latest Holdings Summary

Sherry Aulin currently owns a total of 1 stock. Sherry Aulin owns 0 shares of Xenon Pharmaceuticals Inc (XENE) as of September 2, 2022, with a value of $0.

Latest Holdings of Sherry Aulin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XENE Xenon Pharmaceuticals Inc 2022-09-02 0 43.36 0

Holding Weightings of Sherry Aulin


Sherry Aulin Form 4 Trading Tracker

According to the SEC Form 4 filings, Sherry Aulin has made a total of 1 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 15,355 shares on September 2, 2022, which brought Sherry Aulin around $607,597.

Insider Trading History of Sherry Aulin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sherry Aulin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sherry Aulin Ownership Network

Ownership Network List of Sherry Aulin

No Data

Ownership Network Relation of Sherry Aulin

Insider Network Chart

Sherry Aulin Owned Company Details

What does Xenon Pharmaceuticals Inc do?

Who are the key executives at Xenon Pharmaceuticals Inc?

Sherry Aulin is the Chief Financial Officer of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .

Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary

Over the past 18 months, Sherry Aulin made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .

In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.

Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xenon Pharmaceuticals Inc Insider Transactions

No Available Data

Sherry Aulin Mailing Address

Above is the net worth, insider trading, and ownership report for Sherry Aulin. You might contact Sherry Aulin via mailing address: 200 - 3650 Gilmore Way, Burnaby A0 V5g 48w.